Brand

Sato Pharmaceutical Inc. Recalls

8 recalls on record. Search official CPSC, FDA, and USDA datasets for every recall issued for Sato Pharmaceutical Inc..

8Total Recalls
0Critical
430,745Units Affected
Oct 1, 2019Most Recent
All Recalls

Every Sato Pharmaceutical Inc. Recall

Sorted by most recent. Click any recall for full details.

8 recalls
Medium RiskFDA
Sato Pharmaceutical Inc.
Motion Sickness (meclizine hydrochloride) 25 mg tablets, 12-count box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Sui...
Oral Drugs·210,744 affected·Oct 1, 2019
RecallFDA
Sato Pharmaceutical Inc.
Sankaijo BOTANICAL LAXATIVE (docusate sodium 8.33 mg and sennosides 1.36 mg) tablets, 150-count bottles, Manufactured by SATO PHARMACEUTI...
Oral Drugs·17,284 affected·Oct 1, 2019
RecallFDA
Sato Pharmaceutical Inc.
Motion Sickness Strips (meclizine hydrochloride) 25 mg strips, 8-count box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave....
Drugs·39,504 affected·Oct 1, 2019
Medium RiskFDA
Sato Pharmaceutical Inc.
WAL-DRAM 2 (meclizine Hydrochloride) 25 mg tablets, packaged in a) 12 count (NDC 0363-1407-01, UPC 3 11917-18328 2 ) and b) 18-count boxe...
Oral Drugs·112,104 affected·Oct 1, 2019
RecallFDA
Sato Pharmaceutical Inc.
Zentrip (meclizine Hydrochloride), 25 mg strips, 8-strips per box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 2...
Drugs·21,864 affected·Oct 1, 2019
High RiskFDA
Sato Pharmaceutical Inc.
Optic Splash (naphazoline hydrochloride) Eye Drops, packaged in 0.5 FL OZ (15mL) bottles, Manufactured by SATO Pharmaceuticals CO., LTD. ...
Ophthalmic Drugs·10,130 affected·Feb 16, 2017
High RiskFDA
Sato Pharmaceutical Inc.
DORAMA-NEO (naphazoline hydrochloride) Eye wash, packaged in 0.5 FL OZ (15mL) bottles, Manufactured by SATO Pharmaceuticals CO., LTD. 1-5...
Drugs·14,325 affected·Feb 16, 2017
High RiskFDA
Sato Pharmaceutical Inc.
SATO CLEAR (naphazoline hydrochloride) Redness Reliever Eye Drops, packaged in 0.5 FL OZ (15mL) bottles, Manufactured by SATO Pharmaceuti...
Ophthalmic Drugs·4,790 affected·Feb 16, 2017